Holen Sie sich die Stockscreener-App
5.16
6.18%
-0.34
Handel nachbörslich:
5.30
0.14
+2.71%
Schlusskurs vom Vortag:
$5.50
Offen:
$5.47
24-Stunden-Volumen:
599.28K
Relative Volume:
0.52
Marktkapitalisierung:
$501.72M
Einnahmen:
$1.91M
Nettoeinkommen (Verlust:
$-94.23M
KGV:
-2.0231
EPS:
-2.5505
Netto-Cashflow:
$-79.76M
1W Leistung:
+0.98%
1M Leistung:
-16.77%
6M Leistung:
+17.27%
1J Leistung:
+60.25%
1-Tages-Spanne:
$5.16
$5.625
1-Wochen-Bereich:
$5.14
$5.80
52-Wochen-Spanne:
$2.34
$6.9494
Anteris Technologies Global Corp Stock (AVR) Company Profile
Firmenname
Anteris Technologies Global Corp
Sektor
Telefon
651-493-0606
Adresse
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
5.16 | 534.78M | 1.91M | -94.23M | -79.76M | -2.5505 |
ISRG
Intuitive Surgical Inc
|
452.58 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.32 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.63 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.88 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.93 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2026-03-11 | Eingeleitet | Wells Fargo | Overweight |
| 2025-01-08 | Eingeleitet | Lake Street | Buy |
| 2025-01-07 | Eingeleitet | Barclays | Overweight |
| 2025-01-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
Alle ansehen
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market - Proactive financial news
AVR Stock Price, Quote & Chart | ANTERIS TECHNOLOGIES GLOBAL (NASDAQ:AVR) - ChartMill
Anteris Technologies Cleans Up Capital Structure as RSUs and Options Lapse - tipranks.com
JPMorgan Chase & Co. Boosts Holdings in Anteris Technologies Global Corp. $AVR - MarketBeat
Levels Update: Is Anteris Technologies Global Corp a turnaround story2026 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Fidelity High Income Fund's Anteris Technologies Global Corp(AVR) Holding History - GuruFocus
Investor Mood: Does Anteris Technologies Global Corp have strong EBITDA margins2026 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
How cyclical is Anteris Technologies Global Corps revenue streamTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Anteris Technologies Global's (AVR) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald reiterates Anteris Technologies stock Overweight rating - Investing.com
Cantor Fitzgerald reiterates Anteris Technologies stock Overweight rating By Investing.com - Investing.com Canada
Dividend Watch: Is Anteris Technologies Global Corp part of any ETF2026 Investor Takeaways & Low Volatility Stock Suggestions - baoquankhu1.vn
Anteris (AVR) registers 9.10M shares; up to $40.4M if warrants exercised - Stock Titan
Trend Recap: Will Anteris Technologies Global Corp outperform small cap indexes2026 Performance Recap & Low Risk High Win Rate Picks - baoquankhu1.vn
[EFFECT] Anteris Technologies Global Corp. SEC Filing - stocktitan.net
Barclays Remains a Buy on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Value Recap: Should I hold or sell Anteris Technologies Global Corp nowTrade Analysis Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Anteris Technologies (AVR) Receives Overweight Rating from Canto - GuruFocus
Anteris Technologies Global (NASDAQ:AVR) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy - Yahoo Finance
Wells Fargo Initiates a Buy Rating on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris Issues 78,740 Unquoted RSUs Under Employee Incentive Plan - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Wells Fargo initiates Anteris Technologies stock at Overweight - Investing.com
Wells Fargo initiates Anteris Technologies stock at Overweight By Investing.com - Investing.com India
Total non-current liabilities of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
ASX Biotech Gem: Analyst Predicts 50% Surge - indonesiakini
Anteris registers 9.1M shares for resale in S-1 amendment (AVR) - Stock Titan
Growth Value: Is Anteris Technologies Global Corp part of any ETF2026 Year in Review & Verified Technical Signals - baoquankhu1.vn
Highs Report: What is Anteris Technologies Global Corp.’s market position2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Should I hold or sell Anteris Technologies Global Corp now2025 Macro Impact & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Anteris Technologies (AVR) CFO awarded 78,740 RSUs vesting 2027–2029 - Stock Titan
AVR Stock Pops Pre-Market: Medtronic Backs $200M Capital Raise To Fund Key Trial - Stocktwits
Cantor Fitzgerald Upgrades Anteris Technologies Global (NASDAQ:AVR) to Strong-Buy - MarketBeat
AVR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference - MarketBeat
Anteris adjusts CDI and common stock balances between ASX and Nasdaq - TipRanks
Retail Trends: Should I hold or sell Anteris Technologies Global Corp nowWatch List & Real-Time Buy Signal Notifications - baoquankhu1.vn
Anteris Options Lapse Trims Equity-Linked Securities Pool - TipRanks
Anteris Technologies grants Matthew McDonnell $500,000 RSU award - TradingView
AVRAnteris Reports 2025 Financial Results and Provides Corporate Update - mx.advfn.com
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris net operating cash outflows hit USD 77.8M in FY 2025 - Medical Buyer
AVR Should I Buy - Intellectia AI
Anteris Reports 2025 Financial Results and Provides Corporate Update - The Manila Times
Anteris ramps up pivotal DurAVR trial on strong 2025 progress and fresh funding - TipRanks
Anteris widens 2025 loss as IPO funds fuel heart valve development - TipRanks
Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underway - Yahoo Finance
Anteris Technologies Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Anteris Technologies Global Corp. (AVR) Gets a Buy from Barclays - The Globe and Mail
Finanzdaten der Anteris Technologies Global Corp-Aktie (AVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):